Bmp4
bone morphogenetic protein 4 Dlx1, 2, 5 distal-less homeobox gene 1, 2, or 5 Gro/Tle Groucho/transducin-like enhancer of split kb kilo-base pairs Msx1, 2 homolog of muscle segment homeobox gene, drosophila, 1 or 2 Pax9 paired box gene 9
Pax9 and Msx1 molecular interactions using wild-type and mutant proteins have led to a revision of the original theory about Bmp4 regulation in tooth bud mesenchyme.
In this paper, we present results of our recent studies that further explored the molecular relationship between Pax9, Msx1, and Bmp4 expression as well as the relationship of Pax9 with other mesenchymally expressed transcription factors. Our results suggest that the molecular mechanisms that underlie Bmp4 activation in tooth bud mesenchyme are indeed complex and cannot fully explain the role of Msx1 in normal and abnormal tooth development.
Materials and Methods

Coimmunoprecipitation
Msx1, Msx2, Dlx1, Dlx2, and Dlx5 coding areas were cloned into Flag-tagged pCMV expression vectors (Stratagene); the Pax9 coding region was cloned into a Myc-tagged vector. For coimmunoprecipitation, Pax9-and homeodomain protein-containing vectors were cotransfected (Fugene; Roche) into COS7 cells. Cell lysates were immunoprecipitated with anti-Flag antibodies followed by Western blot with anti-Pax9 antibody.
Promoter Reporter Assays
Bmp4 promoter fragments were PCR amplified and subcloned into pGL3 luciferase reporter vectors (Promega) containing a 0.3-kb proximal Bmp4 promoter segment which served as the minimal baseline promoter. The promoter constructs were cotransfected with increasing amounts of Msx1 expression plasmids (0.0, 0.25, 0.5, and 1 g supplemented with 1.0, 0.75, 0.5, and 0.0 g of empty expression vector, respectively) into COS7 cells and tested for luciferase activity. A pCMV-SPORT b-gal plasmid was used as the internal control. Chandler et al. [2009] kindly provided a BAC clone spanning the upstream 200-kb Bmp4 promoter section.
Cell Culture
Cos7 cells were cultured in DMEM (Invitrogen, USA) supplemented with 10% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 mg/ml). Cells were transfected with plasmids using FuGENE HD (Roche) according to the manufacturer's instructions.
ChIP-PCR
Proteins in dissected molar tooth buds of E14.5 CD1 mouse embryos were cross-linked to chromatin with 1% formaldehyde/1 ! PBS. After enzymatic shearing of the chromatin, a mixture of Pax9 7C2 (Abcam) and M18 (sc-7746; Santa Cruz) antibodies was used to collect antibody-bound protein/DNA complexes using protein G agarose beads. Pax9-bound DNA was purified and analyzed by PCR with primers specific for the Bmp4 promoter. Chromatin precipitated by IgG was used as the negative control.
Results
Pax9-Msx1 Physical and Functional Protein Interaction
We have previously shown that Pax9 and Msx1 can be coimmunoprecipitated, suggesting that both proteins interact physically in order to achieve their synergistic effect on Bmp4 activation. In order to test if this physical interaction is necessary we took advantage of the properties of the related Msx2 protein which is also expressed in tooth bud mesenchyme and shows a similar synergistic effect with Pax9 on Bmp4 expression. The homeodomain of Msx2 differs by only 2 amino acids from the Msx1 homeodomain (98% identity), but the rest of the 2 Msx proteins is quite dissimilar, with only 45% identity. Testing Msx2 for coimmunoprecipitation with Pax9 yielded a negative result ( fig. 1 a) , implying that (a) the protein-protein interaction as demonstrated by coimmunoprecipitation is not involved in the functional synergism with Pax9 and (b) the homeodomain is not responsible for the coimmunoprecipitation of Pax9 and Msx1 but is involved in the functional synergism with Pax9. One Msx1 homeodomain mutant with abolished DNA binding was tested for synergism with Pax9 and found to be even more active than wild-type Msx1 [Wang et al., 2011] , proving that DNA binding by the Msx1 homeodomain is not necessary for the synergistic effect. These experiments also revealed that Msx2 is a more efficient potentiator of Pax9-induced Bmp4 activation than Msx1 when human instead of mouse Bmp4 promoter sequences are used ( fig. 1 b) .
Pax9-Bmp4 Promoter Interaction
Pax9 is unquestionably effective in activating the proximal Bmp4 promoter in vitro, but does this translate to relevance in vivo? A first step was to test if Pax9 is bound to the Bmp4 promoter in mouse embryonic tooth bud mesenchyme. We performed a ChIP-PCR assay using chromatin from E14 tooth buds and a mix of 2 Pax9 antibodies to precipitate Pax9-bound DNA fragments. IgGprecipitated fragments served as the negative control. Figure 2 shows that PCR with Bmp4 promoter-specific primers could amplify several Bmp4 promoter fragments from Pax9-precipitated chromatin but not from IgG-precipitated chromatin, suggesting that Pax9 is indeed bound to the proximal Bmp4 promoter during tooth development.
Msx1-Bmp4 Promoter Interaction
Our previous experiments demonstrated that the proximal 3-kb Bmp4 promoter sequence was unresponsive to Msx1; Msx1 could only potentiate Pax9-induced activation of the Bmp4 promoter. However, recently, Chandler et al. [2009] reported that the regulatory area of Bmp4 extends from about 200 kb upstream to 200 kb downstream of the Bmp4 coding area. They also found that enhancer elements for the tooth bud mesenchyme expression of Bmp4 reside in an upstream extended segment somewhere between -28 and -199 kb. This discovery made it quite obvious that a much larger segment of the promoter region of Bmp4 had to be tested for responsiveness to Msx1 to exclude a direct activation. We subcloned the proximal 97 kb of the extended Bmp4 upstream promoter sequence in 5-to 10-kb segments into pGL3 reporter vectors and cotransfected each subclone with increasing amounts of an Msx1 expression vector into COS7 cells. Figure 1 c shows that Msx1 acted as an inhibitor on all of the segments except the -47-to -42-kb fragment, the same area that had been described by Chandler et al. [2009] as an evolutionary conserved en- hancer element (ECR2)-containing sequence. The isolated 0.67-kb ECR2 enhancer sequence showed a similar effect, while Pax9 was inactive or even inhibitory.
Discussion
Initial investigations of the molecular mechanisms leading to Bmp4 activation by Pax9 and Msx1 strongly suggested a model in which Pax9 directly interacts with the Bmp4 promoter, thus enhancing its transcription. Pax9 also activates the expression of Msx1 protein which subsequently cooperates with Pax9 to amplify Bmp4 transcription. This model also explained the fact that Msx1 by itself was unable to activate Bmp4 expression.
However, further investigations of the molecular interactions between the Bmp4 regulatory region, Pax9, and Msx1 as well as advancing knowledge about the complexities of gene regulation raised questions about the original model. Investigations by Chandler et al. [2009] localized the regulatory region of Bmp4 for tooth bud mesenchyme expression to enhancer elements more than 28 kb upstream of the Bmp4 coding region, which is far beyond the promoter region that had been tested. Some of our molecular interaction studies strengthened our previous model. The Pax9 protein does indeed bind to the proximal Bmp4 promoter in mouse E14 tooth buds according to our ChIP-PCR results. In our investigations about the mechanisms of action of human tooth agenesis-causing Pax9 mutations [Wang et al., 2009] we showed that loss of DNA binding, accompanied by corresponding reductions of reporter gene expression, appears to be the pathogenic effect of these Pax9 mutants. There remains some uncertainty about our results because the DNA region which was tested in these assays spans the proximal 3 kb of the Bmp4 regulatory area and not the upstream segments described by Chandler et al. [2009] . However, it may be possible that in tooth bud mesenchyme Pax9 is a constitutive occupant of the proximal core promoter region which is then targeted by tissuespecific, active enhancer elements from 28 to 200 kb upstream to form a viable transcription factor complex.
The interaction between Pax9 and Msx1 has become less clear. Coimmunoprecipitation of Pax9 and Msx1 is not likely to be mediated by the homeodomain of Msx1, and the molecular interaction causing coimmunoprecipitation is not the physical basis for the synergism between Pax9 and Msx1; to the contrary, it may reflect the ability of Msx1 to regulate Pax9 protein levels by sequestering Pax9. In vitro tests suggest that the homeodomain of Msx1 (and Msx2) appears to be necessary for the synergistic effect with Pax9, but homeodomain-mediated DNA binding is not required for synergism with Pax9. We recently showed that tooth agenesis-causing Msx1 mutations do not abolish synergism with Pax9 [Wang et al., 2011] , and we reached the conclusion that Msx1 must use an alternative or additional mechanism to activate Bmp4. One tooth agenesis-causing Msx1 mutation which is located in a Gro/Tle-binding site of Msx1 points to a disturbance in transcriptional repression mechanisms [RaveHarel et al., 2005] instead of transcriptional activation.
Direct activation of Bmp4 by Msx1 is unlikely, but it has not been excluded yet because the ECR enhancer in the extended Bmp4 regulatory area responded positively in contrast to the remainder of the 98 kb of tested Bmp4 regulatory area. Overall, the previously established plain and coherent model is no longer supported by these new observations that suggest a high degree of complexity in the physiologic roles and molecular relationship between genes involved in Bmp-mediated signaling during tooth morphogenesis. 
